NYSE:CC
Chemours Co
Chemours Co's revenue grew 0.4% in fiscal 2025 to $5.8B. Free cash flow was $51.0M, 0.9% of revenue.Summary generated from Chemours Co's SEC filings. Latest annual report filed Feb 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$5.8B
Revenue growth+0.4%
Revenue, 5-yr CAGR+3.2%
Gross margin15.5%
Operating marginn/a
Net margin−6.6%
ROICn/a
Return on equity−94.0%
Debt / equity16.40
Free cash flow$51.0M
FCF margin0.9%
Share count change+0.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6,345 | 6,831 | 6,078 | 5,782 | 5,808 |
| Operating income | n/a | n/a | n/a | n/a | n/a |
| Net income | 608 | 578 | −253 | 69 | −386 |
| Free cash flow | 537 | 448 | 186 | −993 | 51 |
Recent filings
- 4Insider transaction report
Oct 1, 2026 - 8-KEntry into a material agreement
Sep 10, 2026 - 8-KRegulation FD disclosure
Sep 9, 2026 - 4Insider transaction report
Aug 13, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KEntry into a material agreement
Jun 24, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 5, 2026